glp 1 for weight loss brands GLP-1 Friendly labels on food becoming more common Wegovy maker challenges Hims, weight-loss

ASEAN Rapid adoption of digital health platforms and e-commerce is fueling demand for weight management and gut health supplements

Biotin-thiamine-responsive basal ganglia disease

The EDICT study, employing diabetes medications (GLP-1 receptor agonist, pioglitazone, metformin) that correct the basic underlying pathophysiologic defects present in type 2 diabetes, convincingly demonstrated that combination therapy produces a greater and more durable reduction in HbA1c than the treat-to-fail approach using diabetes medications (sulfonylureas, metformin, insulin) that do not correct the basic metabolic and cellular defects (insulin resistance and beta-cell dysfunction) present in type 2 diabetes patients

Updated meta-analysis on vitamin supplementation for chronic pruritus: expanding evidence beyond vitamin D

Expert Surgical and Non-Surgical Options Schwannoma Tumors A schwannoma forms a tumor from Schwann cells in your peripheral nervous system or nerve roots